A Multicenter Phase II Study of S-1 for Gemcitabine-Refractory Biliary Tract Cancer
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-013-2106-0
Full Text
Open PDFAbstract
Available in full text
Date
March 24, 2013
Authors
Publisher
Springer Science and Business Media LLC